placeEurope
Contact Us
Animal Health / Covidien Products / Veterinary Capsule Endoscopy / PillCam™ Capsules / PillCam™ Crohn’s Capsule

Overview

Visualize. Assess. Track Crohn’s disease over time.

The PillCam™ Crohn’s platform is the only product that allows physicians to directly and minimally invasively visualize the small bowel and colonic mucosa in a single procedure, potentially reducing the number of exams and making disease management more convenient.1,2 

  • 172 degree field of view (per camera)
  • No sedation
  • No radiation

Comprehensive Visualization

  • Advanced optics and innovative imaging features allow for a thorough evaluation of Crohn's disease activity and assessment of disease over time and may also have a role in assessing mucosal healing after medical therapy1,2 
  • Adaptive Frame Rate (AFR) technology increases the rate of image capture from 4 to 35 frames per second based on the speed of the capsule

Specifications

Indications

The PillCam™ Crohn’s capsule is intended for visualization of the small bowel and colonic mucosa.

  • It may be used in the visualization and monitoring of lesions that may indicate Crohn’s disease.
  • It may be used in the visualization and monitoring of lesions that may be a source of obscure bleeding (either overt or occult).
  • It may be used in the visualization and monitoring of lesions that may be potential causes of iron deficiency anemia (IDA).

The PillCam™ Crohn’s capsule may be used as a tool in the detection of abnormalities of the small bowel and colon. It is intended for use in adults and children from eight years of age.

Contraindications

The PillCam™ Crohn’s video capsule is contraindicated for use under the following conditions:

  • In patients with known or suspected gastrointestinal obstruction, strictures, or fistulas based on the clinical picture or pre-procedure testing and profile.
  • In patients with cardiac pacemakers or other implanted electromedical devices.
  • In patients with swallowing disorders.

Note: The procedure may involve intake of laxatives and prokinetic agents. Refer to the labeling of these agents for their contraindications.

Procedure Risk Information

The risks of the PillCam™ Crohn’s capsule include capsule retention, aspiration, and skin irritation. The risks associated with colon preparation are allergies or other known contraindications to any preparation agents or medications used for the PillCam™ Crohn’s system regimen, according to laxative medication labeling and per physician discretion. Medical, endoscopic, or surgical intervention may be necessary to address any of these complications, should they occur. After ingesting the PillCam™ Crohn’s capsule, and until the capsule is excreted, patients should not be near any source of powerful electromagnetic fields, such as one created near an MRI device. Please refer to the product user manual for detailed information.

Order Information
Order Code Description Unit of Measure Quantity
FGS-0606 PillCam™ Crohn’s Capsule Pack 1
FGS-0607 PillCam™ Crohn’s Capsule Pack 5
FGS-0608 PillCam™ Crohn’s Capsule Pack 10

Specifications

Technology

Visualize with confidence

The PillCam™ Crohn’s system enables you to efficiently assess your patient’s Crohn’s disease and how well it is responding to treatment.

  • Exclusive Adaptive Frame Rate (AFR) technology, which adjusts the rate of image capture to 4 or 35 FPS, depending on the movement speed
  • Minimally invasive procedure is well tolerated by patients1
  • No sedation or radiation required
  • The PillCam™ Crohn’s system may reduce the number of invasive procedures, which may help to increase your patients’ satisfaction

Efficient Assessment of disease activity

Since disease activity doesn’t always correlate to how your patient feels,2,3 it’s important to directly visualize the disease progression or healing. The PillCam™ Crohn’s system enables you to efficiently assess your patient’s Crohn’s disease and how well it is responding to treatment. Here’s how:

  • Compare images and disease progression over time
  • Catalog prescriptions
  • See severity by location
  • Tailor your approach according to your patient’s specific disease state
  • Assess mucosal healing — a hallmark of Crohn’s disease remission
  • * Allows video reviewing and reporting, but not video creation. 
  • 1. Wiarda B, Stolk M, Heine D, Mensink P, Thieme M, Kuipers E, and Stoker J. Patient burden and patient preference: comparing MR enteroclysis, capsule endoscopy and balloon-assisted enteroscopy. Journal of Gastroenterology and Hepatology. 2012;1-30.
  • 2. Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease. Gastroenterol. 2010 Feb;138(2):463.468.
  • 3. Allez M, Lemann M, Bonnet J, Cattan P, Jian R, Modigliani R. Long term outcome of patients with active Crohn’s disease exhibiting extensive and deep ulcerations at colonoscopy. Am J Gastroenterol. 2002 Apr;97(4):947-953.
Corporate Resources
Medtronic Animal Health
Contact Us
©2024 Medtronic